---
schema_version: "secwatch.filing_event.v1"
accession: "0001759655-23-000181"
form_type: "8-K"
ticker: "PRVA"
cik: "0001759655"
company_name: "Privia Health Group, Inc."
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T22:11:04.751880+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Privia Health adds former UnitedHealth CEO Wichmann and Manulife CHRO Kimmet to board

## Summary
- David Wichmann, former CEO of UnitedHealth Group (2017-2021), elected to board effective Aug 1, 2023.
- Pamela Kimmet, CHRO of Manulife, elected to board; Bernstein resigns after Goldman Sachs sale of its stake.
- Board size increased from ten to eleven, then bylaw amendment allows up to fifteen directors.
- Bylaws also remove office of president; effective Aug 1, 2023.
- Wichmann and Kimmet each receive annual cash retainer plus $200k equity RSU grant.

## SEC filing metadata
- accession: 0001759655-23-000181
- form_type: 8-K
- ticker: PRVA
- cik: 0001759655
- company_name: Privia Health Group, Inc.
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759655/000175965523000181/0001759655-23-000181-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759655/000175965523000181/prva-20230731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001759655-23-000181
- JSON: https://secwatch.observer/filing/0001759655-23-000181.json
- Plain text: https://secwatch.observer/filing/0001759655-23-000181.txt

## Key facts
- Executive change
  David Wichmann was elected as Director (Class I) at Privia Health Group, Inc..
  - Action: elected
  - Role: Director (Class I)
  source text: The Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) increased the size of the Board from ten to eleven directors and elected David Wichmann to the Board as a Class I director and Pamela Kimmet to the Board as a Class III director, effective August 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759655/000175965523000181/0001759655-23-000181-index.htm
- Executive change
  Pamela Kimmet was elected as Director (Class III) at Privia Health Group, Inc..
  - Action: elected
  - Role: Director (Class III)
  source text: The Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) increased the size of the Board from ten to eleven directors and elected David Wichmann to the Board as a Class I director and Pamela Kimmet to the Board as a Class III director, effective August 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759655/000175965523000181/0001759655-23-000181-index.htm
- Executive change
  Jeffrey Bernstein resigned as Director (and Chair of Compensation and Nominating and Corporate Governance Committees) at Privia Health Group, Inc..
  - Action: resigned
  - Role: Director (and Chair of Compensation and Nominating and Corporate Governance Committees)
  source text: Jeffrey Bernstein resigned from the Board and as Chair of the Compensation and Nominating and Corporate Governance Committees of the Board, effective August 1, 2023, following Goldman Sachs’ sale of its ownership position in the Company through a secondary offering which closed on May 8, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759655/000175965523000181/0001759655-23-000181-index.htm
- Governance Changes
  Privia Health Group, Inc.: Increased board size from 11 to 15 directors and removed the office of president (effective 2023-08-01).
  - Change: bylaw amendment
  - Effective: 2023-08-01
  source text: Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Board approved the Company’s Third Amended and Restated Bylaws (as so amended and restated, the “Amended Bylaws”), effective August 1, 2023. The Amended Bylaws permit an increase of the size of the Board from eleven to fifteen directors. The Amended Bylaws also reflect the removal of the office of president from the Amended Bylaws.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759655/000175965523000181/0001759655-23-000181-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.